Carisbamate, a novel antiepileptic candidate compound, attenuates alcohol intake in alcohol-preferring rats

Alcoholism: Clinical and Experimental Research

Volumn 33, Issue 8, 2009, Pages 1366-1373

  Rezvani, Amir H ^a   Overstreet, David H ^b   Vaidya, Anil H ^c   Zhao, Boyu ^c   Levin, Edward D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Alcohol Drinking; Alcoholism; Naltrexone; P Rats; Relapse and Craving; RWJ 333369; Saccharin; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; CARISBAMATE; NALTREXONE; SACCHARIN; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FOOD INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ALCOHOL DRINKING; ANIMALS; ANTICONVULSANTS; CARBAMATES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 68149128403     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2009.00966.x     Document Type: Article

References (59)

1. Anton RE, Moak DH, Ward LR, Latham PK, Malcolm RJ, Dias JK (1999) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 156 : 1658 1764.
2. Bialer M, Johannessen S, Levy RH, Perucca E, Thomson T, White HS (2009) Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (Eilat IX). Epilepsy Res. In Press.
3. Bisaga A, Evans SM (2006) The acute effects of gabapentin in combination with alcohol in heavy drinkers. Drug Alcohol Depend 83 : 25 32.
4. Carroll KM, Nich C, Ball SA, McCance E, Rounsavile BJ (1998) Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction 93 : 713 727.
5. Chick J, Gough K, Falkowski W, Kershaw P, Hore B, Mehtha B, Ritson B, Ropner B, Torley D (1992) Disulfiram treatment of alcoholism. Br J Psychiatry 161 : 84 89.
6. Chick J, Howlett H, Morgan My, Ritson B (2000) United Kingdom multicenter acamprosate study (UKMCAS): a 6-month prospective study of acamprosate verses placebo in preventing relapse after withdrawal from alcohol. Alcohol Alcohol 35 : 176 187.
7. Cowen MS, Rezvani AH, Jarrott B, Lawrence AJ (1999) Ethanol consumption by Fawn-Hooded rats following abstinence: Effects of naltrexone and changes in ̄-opioid receptors density. Alcohol Clin Exp Res 23 : 1008 1014.
8. Deshpande LS, Nagarkatti N, Sombati S, DeLorenzo RJ (2008) The novel antiepileptic drug carisbamate (RWJ 333369) is effective in inhibiting spontaneous recurrent seizure discharges and blocking sustained repetitive firing in cultured hippocampal neurons. Epilepsy Re 79 : 158 165.
9. Enoch MA (2008) The role of GABA (A) receptors in the development of alcoholism. Pahrm Biochem Behav 90 : 95 104.
10. Faught E, Holmes GL, Rosenfeld WE, Novak G, Neto W, Greenspan A, Schmitt J, Yuen E, Reines S, Haas M (2008) Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures. Neurology 71 : 1586 1593.
11. François J, Boehrer A, Nehlig A (2008) Effects of carisbamate (RWJ-333369) in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS. Epilepsia 49 : 393 399.
12. Fuller RK, Branchey L, Brightweli DR, Derman RM, Emrick CD, Iber FL, James KE, Lacoursiere RB, Lee KK, Lowenstam I (1986) Disulfiram treatment of alcoholism: a Veterans Administration cooperative study. JAMA 256 : 1449 1455.
13. Gabriel KI, Cunningham CL (2005) Effects of topiramate on ethanol and saccharin consumption and preference in C57BL/6J mice. Alcohol Clin Exp Res 29 : 75 79.
14. Gardell LR, Whalen CA, Chambers MD, Boswell KJ, Hubbell CL, Reid LD (1998) Valporate reduces intake of alcoholic beverage among rats. Behav Pharmacol 9 : 638 639.
15. Grabenstatter HL, Dudek FE (2004) The use of chronic models in antiepileptic drug discovery: the effect of RWJ-333369 on spontaneous motor seizures in rats with kainate-induced epilepsy. Epilepsis 45 (Suppl. 7 197.
16. Grabenstatter HL, Dudek FE (2008) A new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate-induced epilepsy. Epilepsia 49 : 1787 1794.
17. Gremel CM, Gabriel KI, Cunningham CL (2006) Topiramate does not affect the acquisition or expression of ethanol conditioned place preference in DBA/2J or CB57BL/6J mice. Alcohol Clin Exp Res 31 : 1900 1907.
18. Hargreaves GA, McGregor IS (2007) Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats. Alcohol Clin Exp Res 31 : 1900 1907.
19. Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ (2003) Oral topiramate for treatment of alcohol dependence: a randomized controlled trial. The Lancet 361 : 1677.
20. Johnson BA, Swift RM, Addolorato G, Ciraulo DA, Myrick H (2005) Safety and efficacy of GABAergic medications for treating alcoholism. Alcohol Clin Exp Res 29 : 248 254.
21. Johnson BA, Swift RM, Ait-Daoud N, DiClemente CC, Javors MA, Malcolm RJ Jr (2004) Development of novel pharmacotherapies for the treatment of alcohol dendence: Focus on antiepileptics. Alcohol Clin Exp Res 28 : 295 301.
22. Kampov-Polevoy AB, Matthews DB, Gause L, Morrow AL, Overstreet DH (2000) P rats develop physical dependence on alcohol via voluntary drinking: Changes in seizure thresholds, anxiety, and patterns of alcohol drinking. Alcohol Clin Exp Res 24 : 278 284.
23. Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R, Kämpf P, Stracke R, Baehr M, Naber D, Wiedemann K (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 60 : 92 99.
24. Kiefer F, Mann K (2006) Pharmacotherapy and behavioral intervention for alcohol dependence. JAMA 296 : 1727 1728.
25. Knapp CM, Mercado M, Markley TL, Crosby S, Ciraulo DA, Kornetsky C (2007) Zonisamide decreases ethanol intake in rats and mice. Pharm Bioch Behav 87 : 65 72.
26. Koob GF (2004) A role for GABA mechanisms in motivational effects of alcohol. Bichem. Pharmacol 68 : 1515 1525.
27. Kranzler JH, Van Kirk J (2001) Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol Clin Exp Res 25 : 1335 1341.
28. Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenhech RA (2001) Naltrexone in the treatment of alcohol dependence. N Engl J Med 345 : 1734 1739.
29. Maccioni P, Bienkowski P, Carai MA, Gessa GL, Colombo G (2008) Baclofen attenuates cue-induces reinstatement of alcohol-seeking behavior in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend 95 : 284 287.
30. Mann K, Kiefer F, Spanagel R, Littleton J (2008) Acamprosate: recent findings and future research directions. Alcohol Clin Exp Res 32 : 1105 1110.
31. Messiha FS, Butler D, Adams MK (1986) Carbamazepine and ethanol elicited response in rodents. Alcohol 3 : 131 133.
32. Monterosso JR, Flannery BA, Pettinati HM, Oslin DW, Rukstalis M, O'Brien CP, Volpicelli JR (2001) Predicting treatment response to naltrexone: the influence of craving and family history. Am J Addict 10 : 258 268.
33. Nguyen SA, Malcolm R, Middugh LD (2007) Topiramate reduces ethanol consumption by C57BL/6 mice. Synapse 61 : 150 156.
34. Novak GP, Kelley M, Zannikos P, Klein B (2007) Carisbamate (RWJ-333369). Neurotherapeutics 4 : 106 109.
35. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B (1992b) Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 49 : 881. 887.
36. O'Malley SS, Jaffe A, Chang G, Wite G, Schottenfeld RS, Rounsaville BJ (1992a) Naltrexone in the treatment of alcohol dependence: preliminary findings, in Novel Pharmacological Interventions for Alcoholism (Naranjo C ed pp 148 157. Springer, Verlag, New York.
37. Overstreet DH, Cui CL, May YY, Guo CY, Han JS, Lukas SE, Lee DY (2008) Electroacupuncture reduces voluntary alcohol intake in alcohol-preferring rats via an opiate-sensitive mechanism. Neurochem Res 33 : 2166 6170.
38. Overstreet DH, Kampov-Polevoy AB, Rezvani AH, Braun C, Bartus RB, Crews F (1999) Suppression of alcohol intake by chronic naloxone treatment in P rats: Tolerance development and elevation of opiate receptor binding. Alcohol Clin Exp Res 23 : 1761 1771.
39. Overstreet DH, Lee Y-W, Rezvani AH, Chen TC (1998) The Chinese herbal medicine NPI-028 suppresses alcohol intake in alcohol-preferring rats and monkeys without inducing taste aversion. Perfusion 11 : 381 390.
40. 2A antagonists amperozide and FG 5974. Alcohol Clin Exp Res 21 : 1448 1454.
41. Rezvani AH, Grady D (1994) Suppression of alcohol consumption by fenfluramine in Fawn-Hooded rats with serotonin dysfunction. Pharmacol Biochem Behav 48 : 105 110.
42. Rezvani AH, Overstreet DH, Lee YW (1995) Attenuation of alcohol intake by Ibogaine in three strains of alcohol preferring rats. Pharmacol Biochem Behav 52 : 615 620.
43. Rezvani AH, Overstreet DH, Levin ED, Rosenthal DI, Kordik CP, Reitz AB, Vaidya AH (2007) The Effects of atypical anxiolytic N-Phenyl-2-[1-[3-(2- pyridinylethynyl)benzoyl]-4-piperidine]acetamide (JNJ-5234801) on alcohol intake in alcohol-preferring P rats: comparison with naltrexone. Alcohol Clin Exp Res 31 : 57 63.
44. Rezvani AH, Overstreet DH, Mason GA, Janowsky DS, Hamedi M, Clark E Jr, Yang Y (2000) Combination pharmacotherapy: A mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats. Alcohol Alcohol 35 : 76 83.
45. Rezvani AH, Overstreet DH, Yang Y, Clark E Jr (1999) Attenuation of alcohol intake by the extract of Hypericum Perforatum (St. John's Wort) in two different strains of alcohol-preferring rats. Alcohol Alcohol 34 : 699 705.
46. Rezvani AH, Overstreet DH, Yang Y, Maisonneuve IM, Bandarage UK, Kuehne MD, Glick SD (1997) Attenuation of alcohol consumption by a novel non-toxic ibogaine analog (18-methoxyccoronaridine) in alcohol-preferring rats. Pharmacol Biochem Behav 58 : 615 619.
47. Rodd-Henricks ZA, Bell RL, Kuc KA, Murphy JM, McBride WJ, Lumeng L, Li T-K (2001) Effects of concurrent access to multiple ethanol concentrations and repeated deprivations on alcohol intake in alcohol-preferring rats. Alcohol Clin Exp Res 25 : 1140 1150.
48. Rogawski MA (2006) Diverse mechanisms of antiepileptic drugs in the development pipline. Epilepsy Res 69 : 273 294.
49. Rogawski MA, Löscher W (2004) The neurobiology of antiepileptic drugs. Nature Review Neuroscience 5 : 553 564.
50. Roussaux JP, Hers D, Ferauge M (1996) Does acamprosate diminish the appetite for alcohol in weaned alcoholics? J Pharm Belg 51 : 65 68.
51. Rubio G, Lupez-Munoz F, Alamo C (2006) Effects of lamotrigine in patients with bipolar disorder and alcohol dependence. Bipolar Disorder 8 : 289 293.
52. Rubio G, Ponce G, Jimenez-Arriero MA, Palmo T, Manzanares J, Ferre F (2004) Effects of topiramate in the treatment of alcohol dependence. Pharmacopsychitry 37 : 37 40.
53. Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME (2005) Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 62 : 37 45.
54. Sinclair JD, Li TK (1989) Long and short alcohol deprivation: effects of AA and alcohol preferring rats. Alcohol 6 : 505 509.
55. Tsai G, Gastfriend DR, Coyle JT (1995) The glutamatergic basis of human alcoholism. Am J Psych 152 : 332 340.
56. Vengeliene V, Bilbao A, Molander A, Spanagel R (2008) Neuropharmacology of alcohol addiction. British J Pharmacol 154 : 299 315.
57. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49 : 876 880.
58. White HS, Srivastava A, Klein B, Zhao B, Choi YM, Gordon R, Lee SJ (2006) The novel investigational neuromodulator RWJ 333369 displays a broad-spectrum anticonvulsant profile in rodent seizure and epilepsy models (abstract). Epilepsia 47 (Suppl. 4 200.
59. Yao C, Doose DR, Novak G, Bialer M (2006) Pharmacokinetics of the new antiepileptic and CNS drug RWJ-333369 following single and multiple dosing to humans. Epilepsis 47 : 1822 1829.